(Q40134534)

17 September 2017

title

Inhibition of tumor growth by a truncated and soluble form of melanotransferrin (English)

1 reference

17 September 2017

Yannève Rolland

1

1 reference

17 September 2017

Michel Demeule

series ordinal

2

1 reference

17 September 2017

Jonathan Michaud-Levesque

series ordinal

3

1 reference

17 September 2017

Richard Béliveau

series ordinal

4

1 reference

17 September 2017

language of work or name

English

0 references

publication date

14 April 2007

1 reference

Experimental Cell Research

17 September 2017

published in

1 reference

17 September 2017

volume

313

1 reference

17 September 2017

issue

13

1 reference

17 September 2017

page(s)

2910-2919

1 reference

Regulation of plasminogen activation: a role for melanotransferrin (p97) in cell migration

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.013

Inhibition of endothelial cell movement and tubulogenesis by human recombinant soluble melanotransferrin: involvement of the u-PAR/LRP plasminolytic system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.013

The human melanoma associated protein melanotransferrin promotes endothelial cell migration and angiogenesis in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.013

Stimulation of cell surface plasminogen activation by membrane-bound melanotransferrin: a key phenomenon for cell invasion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.013

Serum melanotransferrin, p97 as a biochemical marker of Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.013

Human melanoma-associated antigen p97 is structurally and functionally related to transferrin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.013

Melanotransferrin induces human melanoma SK-Mel-28 cell invasion in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.013

The function of melanotransferrin: a role in melanoma cell proliferation and tumorigenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.013

In vivo inhibition of angiogenesis by a soluble form of melanotransferrin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.013

The effect of surgical treatment on survival from early lung cancer. Implications for screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.013

Chemotherapy of malignant gliomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.013

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.013

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.013

Carboxypeptidase B inhibitors reduce tissue factor-induced renal microthrombi in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.013

Antiangiogenic gene therapy in a rat glioma model using a dominant-negative vascular endothelial growth factor receptor 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.013

Prognostic significance of microvessel density determined by an anti-CD105/endoglin monoclonal antibody in astrocytic tumors: comparison with an anti-CD31 monoclonal antibody.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.013

Low density lipoprotein (LDL) receptor-related protein 1B impairs urokinase receptor regeneration on the cell surface and inhibits cell migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.013

The very low density lipoprotein receptor regulates urokinase receptor catabolism and breast cancer cell motility in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.013

Enhanced expression of the LDL receptor family member LR11 increases migration of smooth muscle cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.013

Antiangiogenic therapy of transgenic mice impairs de novo tumor growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.013

Increased angiogenic capabilities of endothelial cells from microvessels of malignant human gliomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.013

Microvessel density is a prognostic indicator for patients with astroglial brain tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.013

Prognostic value of vascular endothelial growth factor and its receptors Flt-1 and Flk-1 in astrocytic tumours.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.013

CD105 antagonizes the inhibitory signaling of transforming growth factor beta1 on human vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.013

7 January 2021

CD 105 and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.013

Breast carcinoma: comparative study of tumor vasculature using two endothelial cell markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.013

The urokinase-type plasminogen activator system in cancer metastasis: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.013

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.04.013

10.1016/J.YEXCR.2007.04.013

7 January 2021

Identifiers

DOI

1 reference

17 September 2017

1 reference